Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ensayo Clínico de Fase III, Aleatorio, Doble Ciego y Controlado Con Placebo Paralelo, Para Evaluar la Seguridad y la Eficacia Protectora de la Vacuna Inactivada Contra el SARS-CoV-2 en la Población Sana de 18 años o más, en Perú

NCT04612972 is registered in ClinicalTrials.gov with Universidad Peruana Cayetano Heredia as lead sponsor.

NCT NCT04612972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04612972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ensayo Clínico de Fase III, Aleatorio, Doble Ciego y Controlado Con Placebo Paralelo, Para Evaluar la Seguridad y la Eficacia Protectora de la Vacuna Inactivada Contra el SARS-CoV-2 en la Población Sana de 18 años o más, en Perú
Lead sponsor
Universidad Peruana Cayetano Heredia
Phase
Phase 3
Overall status
Completed
Start date
September 9, 2020
Completion date
April 3, 2023
Enrollment
12,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19